Dabigatran etexilate is an oral direct thrombin ... for secondary stroke prevention in patients with nonvalvular atrial fibrillation. Under-utilization and under-coagulation are the main problems ...

Are the novel anticoagulants better than warfarin for patients with atrial fibrillation? J Thorac Dis. 2015;7(2):165-171. doi: 10.3978/j.issn.2072-1439.2015.01.23. 20. Pradaxa (dabigatran ...

The most valuable market for OACs is long-term therapy for the prevention of stroke in patients with atrial fibrillation, and dabigatran etexilate might achieve approval for this indication in ...

Atrial fibrillation (AF) is the most common cardiac arrhythmia, and its incidence increases with age. Current data suggest that anticoagulation with warfarin or dabigatran is far superior to ...

Atrial fibrillation is the most common chronic arrhythmia. It is characterized by erratic atrial electrical activity with atrial rates of 400 to 600 beats per minute. The P wave is absent on the ...